PIERIS PHARMACEUTICALS INC's ticker is and the CUSIP is 720795953. A total of 2 filers reported holding PIERIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $14,640 | -6.2% | 15,000 | 0.0% | 0.00% | – |
| Q4 2022 | $15,600 | -8.2% | 15,000 | 0.0% | 0.00% | – |
| Q3 2022 | $17,000 | +142.9% | 15,000 | +525.0% | 0.00% | – |
| Q1 2022 | $7,000 | -83.3% | 2,400 | -78.2% | 0.00% | – |
| Q4 2021 | $42,000 | -64.4% | 11,000 | -51.8% | 0.00% | – |
| Q3 2021 | $118,000 | -76.4% | 22,800 | -82.5% | 0.00% | -100.0% |
| Q2 2021 | $499,000 | +3226.7% | 130,400 | +2932.6% | 0.00% | – |
| Q3 2019 | $15,000 | +400.0% | 4,300 | +760.0% | 0.00% | – |
| Q1 2018 | $3,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 15,000 | $14,640 | 0.00% |